Devesh is working as a CEO in a company. He has a traveling job. He is a known diabetic, controlled on oral hypoglycemic drugs. On his recent visit to the doctor, his blood pressure was found to be 164/102 mm Hg. Most suitable drug for this patient should be?
First, I need to recall the guidelines for hypertension in diabetics. The core concept here is that diabetics are at higher risk for cardiovascular disease and renal complications, so their blood pressure management is crucial. The main goal is to protect the kidneys and reduce the risk of stroke and heart disease.
The correct answer is likely an ACE inhibitor or ARB. These drugs are first-line in diabetics because they reduce proteinuria and slow the progression of diabetic nephropathy. They also have a beneficial effect on the cardiovascular system.
Looking at the options (though they aren't listed here), common antihypertensives include beta-blockers, diuretics, calcium channel blockers, ACE inhibitors, ARBs, etc. Beta-blockers might not be the best here unless there's a specific contraindication or comorbidity like heart failure. Diuretics can be used but may affect blood sugar levels. Calcium channel blockers are effective but don't offer the renal protection that ACE/ARBs do. Thiazide diuretics can increase glucose levels, so they might not be ideal for a diabetic.
So, the correct drug would be an ACE inhibitor like lisinopril or an ARB like losartan. These are recommended in guidelines for diabetic patients with hypertension. The wrong options would be beta-blockers, diuretics, or calcium channel blockers because they don't provide the same renal protective effects and may have adverse metabolic effects.
The clinical pearl here is that for diabetics with hypertension, ACE inhibitors or ARBs are first-line due to their renal and cardiovascular benefits. Students should remember this as a high-yield point for exams like NEET PG or USMLE.
**Core Concept**
This question assesses the optimal antihypertensive therapy for diabetic patients with hypertension. The key principle is that **angiotensin-converting enzyme (ACE) inhibitors** or **angiotensin receptor blockers (ARBs)** are first-line in diabetes due to their **renal protective effects**, reduction of microvascular complications, and favorable metabolic profile.
**Why the Correct Answer is Right**
ACE inhibitors (e.g., lisinopril) or ARBs (e.g., losartan) are preferred in diabetics because they **reduce glomerular hyperfiltration**, **decrease proteinuria**, and **slow progression of diabetic nephropathy**. They also improve insulin sensitivity and have a neutral effect on glucose metabolism, unlike thiazide diuretics or beta-blockers. The **renin-angiotensin-aldosterone system (RAAS)** is overactivated in diabetes, making RAAS inhibition critical for both blood pressure control and organ protection.
**Why Each Wrong Option is Incorrect**
**Option A:** Beta-blockers (e.g., metoprolol) may mask hypoglycemia and worsen insulin sensitivity, increasing diabetes complications.
**Option B:** Thiazide diuretics (e.g., hydrochlorothiazide) can impair glucose tolerance and increase the risk of new-onset diabetes.
**Option C:** Calcium channel blockers (e.g., amlod